Yanfang Zheng

2 ta ish

Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China

1. Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death

   Xiongjie Zhu, Wenkai Zhang, Zhongjian Yu +7

   MaqolaCancer, Stress, Anesthesia, and Immune ResponseTranslational Cancer Research20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.001938

2. Senescence-related signatures predict prognosis and response to immunotherapy in colon cancer

   Xiaoshan Hu, Xiongjie Zhu, Yifan Chen +7

   MaqolaTelomeres, Telomerase, and SenescenceJournal of Gastrointestinal Oncology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.002648